Notice of Discontinuance – Celexa Pregnancy Class Action

IMPORTANT LEGAL NOTICE: The Canadian Celexa Pregnancy Class Action litigation has been DISCONTINUED and THIS CLASS ACTION LITIGATION IS NOT GOING FORWARD.

A proposed class action was commenced on December 22, 2014, by a proposed representative plaintiff  against H Lundbeck A/S and Lundbeck Canada Inc. seeking compensation for individuals who were born with certain birth defects allegedly due to mothers being prescribed Celexa during pregnancy (with the same former lawsuit being known as: Jennifer Price et al. v H Lundbeck A/S et al., Ontario Superior Court Toronto No. CV-14-518695-00CP).

A court ruling has not occurred regarding the merits of those allegations, nor any issues of liability.  Instead, the above proposed class action was discontinued by the Ontario Superior Court Order on November 19, 2025, pursuant to s. 29(1) of the Class Proceedings Act, 1992.

This proposed class action is therefore no longer being pursued (as various attempts to get ‘certified class action’ status ordered by the Courts were ultimately unsuccessful).

PLEASE NOTE: When a proposed class action is commenced, the limitation period(s) [time limits] for starting individual lawsuits against the Defendants are temporarily suspended for potential class members, until such time as the class action is adjudicated, dismissed, or discontinued.  Due to the discontinuance of the above class action, effective February 17, 2026, the limitation period(s) are no longer suspended.

No further steps concerning this matter are being undertaken by Merchant Law Group LLP.  You may email heidi@merchantlaw.com should you require any further information regarding this discontinuance.

PLEASE CLICK TO VIEW THE RELATED DISCONTINUANCE NOTICE THAT HAS BEEN APPROVED BY THE COURT – see Annex 1 and 2 of the PDF.